ストックスクリーナーアプリを入手
112.14
0.14%
0.16
アフターアワーズ：
111.50
-0.64
-0.57%
前日終値:
$111.98
開ける：
$111.98
24時間の取引高:
2.10M
Relative Volume:
0.85
時価総額：
$14.56B
収益：
$692.26M
当期純損益:
$-512.41M
株価収益率:
-26.45
EPS:
-4.24
ネットキャッシュフロー:
$-274.36M
1週間 パフォーマンス:
+1.79%
1か月 パフォーマンス:
+12.14%
6か月 パフォーマンス:
+134.55%
1年 パフォーマンス:
+200.56%
1日の値動き範囲:
$110.09
$115.54
1週間の範囲:
$103.80
$115.54
52週間の値動き範囲:
$34.88
$115.54
Guardant Health Inc Stock (GH) Company Profile
GH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
112.14 | 14.54B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
618.72 | 234.69B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.99 | 169.45B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
715.37 | 56.86B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
237.68 | 41.09B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
139.64 | 41.06B | 6.95B | 1.30B | 1.15B | 4.5696 |
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-05 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2025-12-02 | 再開されました | Morgan Stanley | Overweight |
| 2025-09-25 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-09-22 | 再開されました | Wells Fargo | Overweight |
| 2025-04-10 | 開始されました | Mizuho | Outperform |
| 2025-01-23 | 開始されました | Barclays | Overweight |
| 2024-06-28 | アップグレード | Guggenheim | Neutral → Buy |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-24 | 再開されました | Craig Hallum | Buy |
| 2023-12-14 | 開始されました | Guggenheim | Neutral |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-11-13 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-27 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-26 | アップグレード | Citigroup | Neutral → Buy |
| 2023-05-05 | 開始されました | UBS | Buy |
| 2023-03-09 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-11-01 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | 開始されました | Craig Hallum | Buy |
| 2022-10-06 | 開始されました | Stephens | Overweight |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-06-03 | 開始されました | Piper Sandler | Overweight |
| 2022-04-28 | 再開されました | BTIG Research | Buy |
| 2022-02-24 | 繰り返されました | Canaccord Genuity | Buy |
| 2022-02-24 | 繰り返されました | Citigroup | Buy |
| 2022-02-24 | 繰り返されました | Cowen | Outperform |
| 2022-02-24 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-24 | 繰り返されました | SVB Leerink | Outperform |
| 2022-02-24 | 繰り返されました | Stifel | Buy |
| 2022-02-24 | 繰り返されました | Wells Fargo | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-15 | 開始されました | Raymond James | Mkt Perform |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-05-25 | 開始されました | Wells Fargo | Overweight |
| 2021-01-11 | 開始されました | Stifel | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-06-12 | 開始されました | BTIG Research | Buy |
| 2020-02-21 | 開始されました | Guggenheim | Buy |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-08-07 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-04-16 | 開始されました | Canaccord Genuity | Buy |
| 2019-04-10 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | 繰り返されました | BofA/Merrill | Neutral |
| 2018-10-29 | 開始されました | BofA/Merrill | Neutral |
| 2018-10-29 | 開始されました | JP Morgan | Overweight |
| 2018-10-29 | 開始されました | William Blair | Outperform |
すべてを表示
Guardant Health Inc (GH) 最新ニュース
Guardant Health: Shield Colorectal Cancer Screening To Sustain Growth - Seeking Alpha
Guardant Health stock hits 52-week high at 113.98 USD By Investing.com - Investing.com Nigeria
IPO Launch: How does Guardant Health Inc compare to its peersJuly 2025 Reactions & Daily Profit Maximizing Tips - baoquankhu1.vn
Guardant Health stock hits 52-week high at 113.98 USD - Investing.com India
Sumitomo Mitsui Trust Group Inc. Has $47.12 Million Position in Guardant Health, Inc. $GH - MarketBeat
Global Pan-Genomic and Multi-Gene Panel Testing Market Forecast to Hit US$ 25.91 Billion by 2032 at 12.04% CAGR, Driven by Growing Demand for Comprehensive Multi-Gene Diagnostics: AnalystView Market Insights - GlobeNewswire Inc.
BLOODPAC Publishes New Standards for Liquid Biopsy Tests That Monitor for Cancer Recurrence - PA Media
Guardant Health (NASDAQ:GH): Strongest Q3 Results from the Testing & Diagnostics Services Group - Yahoo Finance
Guardant Health Announces Strong 2025 Preliminary Revenue Growth - The Globe and Mail
Guardant Health guides Q4 and FY25 revenue above consensus - MSN
Guardant Health (NASDAQ:GH) Reaches New 12-Month HighStill a Buy? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), SI-Bone (SIBN) and Guardant Health (GH) - The Globe and Mail
Guardant Health shares up 2.4% after preliminary Q4 revenue beats estimates - marketscreener.com
Guardant Health, Inc. (GH) Stock Analysis: Strong Buy Potential with 38.5% Revenue Growth and Robust Analyst Support - DirectorsTalk Interviews
Guardant Health rises after Q4 revenue surpasses estimate - TradingView — Track All Markets
Guardant Health, Inc. $GH Shares Sold by D.A. Davidson & CO. - MarketBeat
Guardant Health Sees 39% Rise in Q4 Preliminary Revenue - marketscreener.com
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results - BioSpace
Guardant Health (GH) Surpasses Revenue Estimates with Strong Onc - GuruFocus
Guardant Health prelim Q4 revenue rises 39%, beats expectations - TradingView — Track All Markets
Guardant Health Q4 total revenue of approx $280 million - marketscreener.com
Discipline and Rules-Based Execution in GH Response - Stock Traders Daily
Guggenheim Analyst is Bullish on Guardant Health, Inc. (GH) - Finviz
How Recent Analyst Targets Are Shaping The Evolving Story For Guardant Health (GH) - Yahoo Finance
Guardant Health (GH) Is Up 8.3% After TRICARE Adds No-Copay Shield Coverage For Service Members - Yahoo Finance
Is Guardant Health (GH) Share Surge Justified By Recent Valuation Signals? - Yahoo Finance
Guardant Health is the top performing healthcare services stock YTD - MSN
Guardant Health’s Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families in Florida - Florida Hospital News and Healthcare Report
Stifel raises Guardant Health stock price target to $120 on growth outlook - Investing.com Canada
Guardant Health (GH): Stifel Raises Price Target to $120.00 | GH Stock News - GuruFocus
Insider Sell: Terilyn Monroe Sells Shares of Guardant Health Inc (GH) - GuruFocus
Insider Selling: Guardant Health (NASDAQ:GH) Insider Sells 10,031 Shares of Stock - MarketBeat
Clinical Labs Hope to Head Off Looming Medicare Cuts - Barron's
Aug Swings: How strong is Guardant Health Inc. stock balance sheetJuly 2025 Market Mood & Technical Buy Zone Confirmation - ulpravda.ru
How Guardant Health Inc. stock compares to industry benchmarks2025 EndofYear Setup & Expert Curated Trade Setups - ulpravda.ru
Can Guardant Health Inc. stock continue upward trendWeekly Investment Summary & Reliable Breakout Forecasts - ulpravda.ru
Guardant Health’s Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families - The Joplin Globe
Will Guardant Health Inc. stock deliver better than expected guidanceTrendline Breakouts & Rapid Wealth Accumulation - ulpravda.ru
Guardant Health, Inc.Common Stock (NQ: GH - FinancialContent
Assessing Guardant Health (GH) Valuation After Analyst Upgrades And New Cancer Test Partnerships - Yahoo Finance
Guardant Health stock hits 52-week high at 112.43 USD By Investing.com - Investing.com Nigeria
Guardant Health (NASDAQ:GH) Sets New 1-Year HighHere's Why - MarketBeat
Guardant Health stock hits 52-week high at 112.43 USD - Investing.com
Guardant Health stock jumps 7% as Evercore downgrades — what investors watch next - TechStock²
GH Virtual Meeting Scheduled by BTIG for January 12 - GuruFocus
Guardant Health (NASDAQ:GH) Stock Rating Lowered by Evercore ISI - MarketBeat
Evercore ISI Group downgrades Guardant Health (GH) - MSN
GH: Evercore ISI Group Downgrades Guardant Health While Raising Price Target | GH Stock News - GuruFocus
GH: Guggenheim Raises Price Target for Guardant Health to $115 | - GuruFocus
VIRGINIA RETIREMENT SYSTEMS ET Al Takes Position in Guardant Health, Inc. $GH - MarketBeat
Allspring Global Investments Holdings LLC Makes New $39.52 Million Investment in Guardant Health, Inc. $GH - MarketBeat
Guardant Health Inc (GH) 財務データ
収益
当期純利益
現金流量
EPS
Guardant Health Inc (GH) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Monroe Terilyn J. | Chief People Officer |
Jan 15 '26 |
Option Exercise |
0.00 |
17,379 |
0 |
38,369 |
| Monroe Terilyn J. | Chief People Officer |
Jan 07 '26 |
Sale |
112.08 |
10,031 |
1,124,279 |
20,990 |
2.51%
0.74%
大文字化:
|
ボリューム (24 時間):